Pub Date : 2021-01-01DOI: 10.5455/pbs.20210520090145
T. Ulusoy, Ekin Ozaksoy Almbaidheen, N. Baskak, H. Bilek, Mesut Demirköse, M. Akın, A. Kahve
ABSTRACT Background: In addition to its physical effects, COVID-19 also causes significant psychological effects. Our study aimed to investigate the relationship between state and trait anxiety and hopelessness levels of inpatients with sociodemographic variables and length of hospital stay. Methods: 161 patients hospitalized with the diagnosis of COVID-19 who received in-hospital treatment between 20.11.2020-10.01.2021 in hospital were included in the study. After the interview with the patients, the Sociodemographic data form, State-Trait Anxiety Scale and Beck Hopelessness Scale (BHS) were administered online via Google Forms. Results: A significant correlation was detected between participants Trait Anxiety Scale scores and State Anxiety Scale scores (r: 0.436; p
{"title":"The Relationship Between State-Trait Anxiety Levels, Hopelessness Levels And Duration Of Hospitalization In Patients With Covid-19","authors":"T. Ulusoy, Ekin Ozaksoy Almbaidheen, N. Baskak, H. Bilek, Mesut Demirköse, M. Akın, A. Kahve","doi":"10.5455/pbs.20210520090145","DOIUrl":"https://doi.org/10.5455/pbs.20210520090145","url":null,"abstract":"ABSTRACT Background: In addition to its physical effects, COVID-19 also causes significant psychological effects. Our study aimed to investigate the relationship between state and trait anxiety and hopelessness levels of inpatients with sociodemographic variables and length of hospital stay. Methods: 161 patients hospitalized with the diagnosis of COVID-19 who received in-hospital treatment between 20.11.2020-10.01.2021 in hospital were included in the study. After the interview with the patients, the Sociodemographic data form, State-Trait Anxiety Scale and Beck Hopelessness Scale (BHS) were administered online via Google Forms. Results: A significant correlation was detected between participants Trait Anxiety Scale scores and State Anxiety Scale scores (r: 0.436; p","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"346 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73922833","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210418021614
M. Arslan, İshak Aydemir
{"title":"Prevelance of Caffeine and Catechin Consumption among University Students with The effect of it's on Depression and Stress","authors":"M. Arslan, İshak Aydemir","doi":"10.5455/pbs.20210418021614","DOIUrl":"https://doi.org/10.5455/pbs.20210418021614","url":null,"abstract":"","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"12 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84493812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210718061756
Y. Torun, Hesna Gul, M. Şahin, Ozlem Hekim, B. Ateş, Şahin Bodur, A. Gul, M. Congologlu
{"title":"Daydreaming and Sluggishness May Predict Different Functions for Non-Suicidal Self-Injury: A Clinic-Based Single-Center Study","authors":"Y. Torun, Hesna Gul, M. Şahin, Ozlem Hekim, B. Ateş, Şahin Bodur, A. Gul, M. Congologlu","doi":"10.5455/pbs.20210718061756","DOIUrl":"https://doi.org/10.5455/pbs.20210718061756","url":null,"abstract":"","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"18 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74243931","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210503104148
Bahadır Demir, Ş. Şahin, I. Kilic, A. Altındağ
Objective: ECT is still an important treatment modality in contemporary psychiatry. Despite the evidence regarding its efficacy and safety, patients are hesitant about ECT, which is sometimes stigmatized due to disinformation. Today, YouTube, an online media platform, is mostly used as a medical information source. This study investigated the quality and reliability of electroconvulsive therapy videos available on YouTube. Methods: A video search on YouTube (http://www.youtube.com) was conducted on 20 October 2020, using the keywords electroconvulsive therapy schizophrenia, electroconvulsive therapy depression, and electroconvulsive therapy psychiatric disorders in this descriptive study. After applying the exclusion criteria, a total of 79 videos were included in this study. The Global Quality Scale (GQS) was used to assess educational quality and the modified DISCERN tool was used to assess reliability. Video parameters (the numbers of views, likes, dislikes, and comments for per day) were compared among the low/medium/high quality groups. Results: 45.2% (n: 42) of the videos were of low quality, 25.8% (n: 24) were of medium quality and 14% (n: 13) were of high quality. High-quality videos were 38.5% from psychiatrists, 23.1% from academic resources, 23.1% from health-related websites. Modified DISCERN scores were higher in the high quality video group (p
{"title":"Assessment of Quality and Reliability of Electroconvulsive Therapy Videos Available on YouTube","authors":"Bahadır Demir, Ş. Şahin, I. Kilic, A. Altındağ","doi":"10.5455/pbs.20210503104148","DOIUrl":"https://doi.org/10.5455/pbs.20210503104148","url":null,"abstract":"Objective: ECT is still an important treatment modality in contemporary psychiatry. Despite the evidence regarding its efficacy and safety, patients are hesitant about ECT, which is sometimes stigmatized due to disinformation. Today, YouTube, an online media platform, is mostly used as a medical information source. This study investigated the quality and reliability of electroconvulsive therapy videos available on YouTube. Methods: A video search on YouTube (http://www.youtube.com) was conducted on 20 October 2020, using the keywords electroconvulsive therapy schizophrenia, electroconvulsive therapy depression, and electroconvulsive therapy psychiatric disorders in this descriptive study. After applying the exclusion criteria, a total of 79 videos were included in this study. The Global Quality Scale (GQS) was used to assess educational quality and the modified DISCERN tool was used to assess reliability. Video parameters (the numbers of views, likes, dislikes, and comments for per day) were compared among the low/medium/high quality groups. Results: 45.2% (n: 42) of the videos were of low quality, 25.8% (n: 24) were of medium quality and 14% (n: 13) were of high quality. High-quality videos were 38.5% from psychiatrists, 23.1% from academic resources, 23.1% from health-related websites. Modified DISCERN scores were higher in the high quality video group (p","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"85473477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210214012334
E. Aydın, Meral Gunes Ozdogan, M. Üstündağ, H. Ceyhun, I. S. Esin
Background: Previously it has been shown that patients with bipolar disorder (BD) have significant functional impairments even if they are in remission. Here we aimed to assess the effects of clinical factors, neurocognitive functions and dysfunctional attitudes on psychosocial functioning in remitted patients with BD type 1. Methods: Patients were enrolled (n=51) after screening with Structured Clinical Interview for DSM-IV-TR axis I disorders (SCID-I), Hamilton Depression Rating Scale (HAM-D-17) and Young Mania Rating Scale (YMRS). Neurocognitive functions were evaluated with Stroop Colour Word and Interference Test TBAG Form (SCWT) and Trail Making Tests A and B (TMT-A/B). Dysfunctional attitudes were evaluated with Dysfunctional Attitude Scale Revised Form (DAS-R), functioning was evaluated with Sheehan Disability Scale (SDS). Results: Functioning scores were not related with dysfunctional attitudes, subclinical symptoms or neurocognitive functions. Only previous hospitalization number of patients (r = 0.341, p = 0.01) and age of patients (r = 0.295, p = 0.04) were significantly related with functioning of patients. Conclusion: Hospitalization number and older age were inversely related with functioning. Due to our results, previous hospitalization and age of patients may be evaluated in daily clinical practice in euthymic patients with BD type 1 to assess their influence on the psychosocial functioning of BD patients.
背景:先前已有研究表明,双相情感障碍(BD)患者即使处于缓解期,也存在显著的功能障碍。在这里,我们旨在评估临床因素、神经认知功能和功能失调态度对BD 1型缓解患者心理社会功能的影响。方法:采用DSM-IV-TR I轴障碍(SCID-I)、汉密尔顿抑郁评定量表(HAM-D-17)和青年躁狂症评定量表(YMRS)筛选患者(n=51)。采用Stroop color Word and Interference Test TBAG Form (SCWT)和Trail Making Tests A and B (TMT-A/B)评估神经认知功能。功能失调性态度采用功能失调性态度量表(DAS-R)评估,功能失调性态度采用Sheehan残疾量表(SDS)评估。结果:功能评分与功能失调性态度、亚临床症状或神经认知功能无关。只有患者既往住院次数(r = 0.341, p = 0.01)和患者年龄(r = 0.295, p = 0.04)与患者功能有显著相关性。结论:住院次数与年龄与功能呈负相关。根据我们的研究结果,可以在日常临床实践中评估健康BD 1型患者的住院史和患者年龄,以评估其对BD患者心理社会功能的影响。
{"title":"Functioning, dysfunctional attitudes and neurocognitive functions in euthymic patients with bipolar disorder type 1.","authors":"E. Aydın, Meral Gunes Ozdogan, M. Üstündağ, H. Ceyhun, I. S. Esin","doi":"10.5455/pbs.20210214012334","DOIUrl":"https://doi.org/10.5455/pbs.20210214012334","url":null,"abstract":"Background: Previously it has been shown that patients with bipolar disorder (BD) have significant functional impairments even if they are in remission. Here we aimed to assess the effects of clinical factors, neurocognitive functions and dysfunctional attitudes on psychosocial functioning in remitted patients with BD type 1. Methods: Patients were enrolled (n=51) after screening with Structured Clinical Interview for DSM-IV-TR axis I disorders (SCID-I), Hamilton Depression Rating Scale (HAM-D-17) and Young Mania Rating Scale (YMRS). Neurocognitive functions were evaluated with Stroop Colour Word and Interference Test TBAG Form (SCWT) and Trail Making Tests A and B (TMT-A/B). Dysfunctional attitudes were evaluated with Dysfunctional Attitude Scale Revised Form (DAS-R), functioning was evaluated with Sheehan Disability Scale (SDS). Results: Functioning scores were not related with dysfunctional attitudes, subclinical symptoms or neurocognitive functions. Only previous hospitalization number of patients (r = 0.341, p = 0.01) and age of patients (r = 0.295, p = 0.04) were significantly related with functioning of patients. Conclusion: Hospitalization number and older age were inversely related with functioning. Due to our results, previous hospitalization and age of patients may be evaluated in daily clinical practice in euthymic patients with BD type 1 to assess their influence on the psychosocial functioning of BD patients.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"7 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"82354008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210419035444
N. Kasar, Ç. Yektaş, A. Tufan
{"title":"Treatment Related Adverse Events in Children with Attention-Deficit / Hyperactivity Disorder Using Atomoxetine","authors":"N. Kasar, Ç. Yektaş, A. Tufan","doi":"10.5455/pbs.20210419035444","DOIUrl":"https://doi.org/10.5455/pbs.20210419035444","url":null,"abstract":"","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"90112485","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2021-01-01DOI: 10.5455/pbs.20210322064056
G. Erdogan, B. Geniş, N. Gürhan, M. Koç, Burak Sirin
Aim: We aimed to investigate the effects of COVID-19 related fears and marital adjustment on distress in pregnant women. Materials and Methods: This study is a cross-sectional descriptive study. The sample of the study consisted of 161 pregnant women who were followed up in a private hospital in Ankara between May and September 2020. Sociodemographic data form, Fear of COVID-19 Scale, Tilburg Pregnancy Distress Scale (TPDS), and Marital Adjustment Scale (MAS) were used in the study. Results: The mean age of the pregnant women in the sample was 29.64±4.47 years. While the rate of chronic disease was 8.7% (n=14), the rate of psychiatric disease was 2.5% (n=4). 7.5% (n=12) of the sample described their current pregnancy as unwanted pregnancy. The negative affect sub-dimension scores of TPDS were predicted by the Fear of COVID-19 Scale score (β=0.473, p
目的:探讨新冠肺炎相关恐惧和婚姻调整对孕妇痛苦的影响。材料与方法:本研究为横断面描述性研究。该研究的样本包括161名孕妇,她们于2020年5月至9月在安卡拉的一家私立医院接受了随访。研究采用社会人口学数据表、新冠病毒恐惧量表、Tilburg妊娠窘迫量表(TPDS)和婚姻适应量表(MAS)。结果:本组孕妇平均年龄为29.64±4.47岁。慢性疾病的发生率为8.7% (n=14),精神疾病的发生率为2.5% (n=4)。7.5% (n=12)的样本将其当前怀孕描述为意外怀孕。TPDS的负性影响子维度得分可通过新冠病毒恐惧量表得分预测(β=0.473, p . 472)
{"title":"The Effect of Marital Adjustment and Fear of COVID-19 on Pregnancy Distress: A Cross-sectional Study in a Pregnancy Sample in Turkey","authors":"G. Erdogan, B. Geniş, N. Gürhan, M. Koç, Burak Sirin","doi":"10.5455/pbs.20210322064056","DOIUrl":"https://doi.org/10.5455/pbs.20210322064056","url":null,"abstract":"Aim: We aimed to investigate the effects of COVID-19 related fears and marital adjustment on distress in pregnant women. Materials and Methods: This study is a cross-sectional descriptive study. The sample of the study consisted of 161 pregnant women who were followed up in a private hospital in Ankara between May and September 2020. Sociodemographic data form, Fear of COVID-19 Scale, Tilburg Pregnancy Distress Scale (TPDS), and Marital Adjustment Scale (MAS) were used in the study. Results: The mean age of the pregnant women in the sample was 29.64±4.47 years. While the rate of chronic disease was 8.7% (n=14), the rate of psychiatric disease was 2.5% (n=4). 7.5% (n=12) of the sample described their current pregnancy as unwanted pregnancy. The negative affect sub-dimension scores of TPDS were predicted by the Fear of COVID-19 Scale score (β=0.473, p","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2021-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74794304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-05-31DOI: 10.20944/preprints202005.0485.v1
H. Gokcay, Y. Balcioglu
Previous incidental findings of an increase of suicidal risk among subjects with low cholesterol levels have drawn attention to the role of lipids in suicidal behavior. To date, multiple lines of evidence acquired from clinical studies have confirmed an association between low cholesterol levels and suicidal behavior, but the involvement of dimensional traits including impulsivity and aggression in this association remains elusive. In this narrative review, we aimed to address and synthesize the literature regarding the involvement of lipids in the neurobiology of suicidal behavior and its underlying psychological substrates, impulsivity and aggression. An electronic database search was performed using different combinations of relevant keywords. Both preclinical and clinical studies matching the scope of this article were reviewed and filtered through an inspection of the abstracts to recruit the most suitable articles that contributed essential and substantial findings to the literature. Although subject characteristics and study designs vary across studies, current research has demonstrated that impulsivity and aggression might have shared neurobiologic substrates involved in altered serotonergic neurotransmission. Despite the association between low serum lipid levels and suicidal behavior being well documented, the involvement of lipid subtypes in the pathophysiology of impulsive and aggressive traits remains elusive. Further work is warranted to recognize the roles of lipids in neuronal membrane functions and serotonin metabolism, promote a greater appreciation of identifying biomarkers that could be used to determine at-risk individuals, and develop potential interventions to disrupt the pathogenesis of behavioral phenotypes of suicide.
{"title":"Neurobiology of Impulsivity and Aggression as Substrates of Suicidal Behavior: A Narrative Focus on the Involvement of Serum Lipids","authors":"H. Gokcay, Y. Balcioglu","doi":"10.20944/preprints202005.0485.v1","DOIUrl":"https://doi.org/10.20944/preprints202005.0485.v1","url":null,"abstract":"Previous incidental findings of an increase of suicidal risk among subjects with low cholesterol levels have drawn attention to the role of lipids in suicidal behavior. To date, multiple lines of evidence acquired from clinical studies have confirmed an association between low cholesterol levels and suicidal behavior, but the involvement of dimensional traits including impulsivity and aggression in this association remains elusive. In this narrative review, we aimed to address and synthesize the literature regarding the involvement of lipids in the neurobiology of suicidal behavior and its underlying psychological substrates, impulsivity and aggression. An electronic database search was performed using different combinations of relevant keywords. Both preclinical and clinical studies matching the scope of this article were reviewed and filtered through an inspection of the abstracts to recruit the most suitable articles that contributed essential and substantial findings to the literature. Although subject characteristics and study designs vary across studies, current research has demonstrated that impulsivity and aggression might have shared neurobiologic substrates involved in altered serotonergic neurotransmission. Despite the association between low serum lipid levels and suicidal behavior being well documented, the involvement of lipid subtypes in the pathophysiology of impulsive and aggressive traits remains elusive. Further work is warranted to recognize the roles of lipids in neuronal membrane functions and serotonin metabolism, promote a greater appreciation of identifying biomarkers that could be used to determine at-risk individuals, and develop potential interventions to disrupt the pathogenesis of behavioral phenotypes of suicide.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"43 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-05-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"87409389","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pbs.20200117070405
S. Qureshi, J. Siddiqui, F. Ayari
Received: Jan 17, 2020 Accepted: Jun 03, 2020 Abstract Epilepsy and mental disorder are comorbid with each other, due to altered cerebral functions. Around 19 to 52 percent of adult patients with epilepsy have psychiatric disorders such as depression, anxiety, psychosis and cognitive and personality changes. This case report recognizes the risk factor for development of psychosis, so clinicians should be vigilant for psychosis in patient with epilepsy. It is also called schizophrenia like psychosis or psychosis of epilepsy and it is under-recognized and under-treated, in child and adolescent patients. Here we present a case of epilepsy presenting with schizophrenia like symptoms and improved with both antipsychotics and antiepileptic.
{"title":"Interictal Psychosis- a case of Psychosis of Epilepsy","authors":"S. Qureshi, J. Siddiqui, F. Ayari","doi":"10.5455/pbs.20200117070405","DOIUrl":"https://doi.org/10.5455/pbs.20200117070405","url":null,"abstract":"Received: Jan 17, 2020 Accepted: Jun 03, 2020 Abstract Epilepsy and mental disorder are comorbid with each other, due to altered cerebral functions. Around 19 to 52 percent of adult patients with epilepsy have psychiatric disorders such as depression, anxiety, psychosis and cognitive and personality changes. This case report recognizes the risk factor for development of psychosis, so clinicians should be vigilant for psychosis in patient with epilepsy. It is also called schizophrenia like psychosis or psychosis of epilepsy and it is under-recognized and under-treated, in child and adolescent patients. Here we present a case of epilepsy presenting with schizophrenia like symptoms and improved with both antipsychotics and antiepileptic.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"207 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77488916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2020-01-01DOI: 10.5455/pbs.20200419092356
Aysegul Kirkas, F. Uguz
Received: Apr 19, 2020 Accepted: May 31, 2020 Abstract Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants. Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice. Few cases of serotonin syndrome due to the use of serotonergic antidepressants and bupropion have been reported in the literature. The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.
{"title":"Serotonin Syndrome in a Patient Using Paroxetine and Bupropion","authors":"Aysegul Kirkas, F. Uguz","doi":"10.5455/pbs.20200419092356","DOIUrl":"https://doi.org/10.5455/pbs.20200419092356","url":null,"abstract":"Received: Apr 19, 2020 Accepted: May 31, 2020 Abstract Serotonin syndrome is an important clinical condition that can occur after excessive central serotonergic activity, generally secondary to the use of combinations of antidepressants. Selective serotonin reuptake inhibitors and bupropion are frequently used in the treatment of major depression in clinical practice. Few cases of serotonin syndrome due to the use of serotonergic antidepressants and bupropion have been reported in the literature. The current case report presents a patient who underwent the serotonin syndrome after the administration of paroxetine and bupropion.","PeriodicalId":74168,"journal":{"name":"MedPress psychiatry and behavioral sciences","volume":"36 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"84317462","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}